Pensions & Investments Logo
ETF Exchange > XPH ETF

XPH - ETF Fact Sheet

State Street SPDR S&P Pharmaceuticals ETF - USD

Fund Identification

Ticker

XPH

ISIN

US78464A7220

Main Metrics

Price

$71.37

Expense Ratio

0.35%

AuM

$613.80M

Tracking Difference

-0.26%

Ratings

Trackinsight rating

Official Investment Strategy

The SPDR® S&P® Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P® Pharmaceuticals Select Industry® Index The S&P Pharmaceuticals Select Industry® Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets IndexTM. The S&P TMI tracks all the U.S. common stocks listed on the NYSE, AMEX, NASDAQ® National Market and NASDAQ Small Cap exchanges. The Pharmaceuticals Index is a modified equal weight index.

XPH's historical prices, performance, and flows

0246810%
1m returns
5.01%
1m flows
$100M
* Net total returns
All data as of 2 September 2026

The ETF Exchange is brought to you by

State Street
With data and analysis by
Trackinsight
See all XPH data with a
free P&I Online account
Enjoy unlimited ETF searches and access to tear-sheets of over 4,000 North-American funds.

XPH's characteristics

Manager statistics

382 funds, $2,339.16Bn in AUM

Benchmark

S&P Pharmaceuticals Select Industry Total Return Index - USD

Replication method

Direct (Physical)

Asset class

Equity

Dividend policy

Distributing
XPH's exposure

Countries

USA
95.20%

Sectors

Healthcare
99.99%

Top 5 holdings

Crinetics Pharmaceuticals, Inc.
3.69%
MBX Biosciences, Inc.
3.22%
Amylyx Pharmaceuticals, Inc.
2.29%
Enliven Therapeutics, Inc.
2.24%
Corcept Therapeutics, Inc.
2.22%
Total holdings
63
Total weight of top 5
13.66%

ETF Education Center

10%